Treatment efficacy for pharyngeal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials

FYS Kong, CL Hatzis, A Lau… - Journal of …, 2020 - academic.oup.com
Background Rising gonorrhoea rates require highly effective treatments to reduce
transmission and prevent development of antimicrobial resistance. Currently the most …

[HTML][HTML] Gonorrhoea

JS Moran - BMJ clinical evidence, 2007 - ncbi.nlm.nih.gov
Results We found 21 systematic reviews, RCTs, or observational studies that met our
inclusion criteria. We performed a GRADE evaluation of the quality of evidence for …

New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance

DA Lewis - Sexual Health, 2019 - CSIRO Publishing
Neisseria gonorrhoeae, the causative agent of gonorrhoea, has rapidly evolved from an
exquisitely susceptible pathogen into a 'superbug'with the capacity to exhibit an extensively …

Adherence to, and acceptability of, Listerine® mouthwash as a potential preventive intervention for pharyngeal gonorrhoea among men who have sex with men in …

VJ Cornelisse, CK Fairley, S Walker, T Young… - Sexual …, 2016 - CSIRO Publishing
We investigated whether men who have sex with men (MSM) would use mouthwash daily to
prevent pharyngeal gonorrhoea. Ten MSM attending the Melbourne Sexual Health Centre …

Future treatment of gonorrhoea–novel emerging drugs are essential and in progress?

M Unemo, WM Shafer - Expert opinion on emerging drugs, 2015 - Taylor & Francis
1. Background Gonorrhoea is a major public health concern, causing significant morbidity
and socioeconomic consequences globally Citation [1]. Neisseria gonorrhoeae has …

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults

C Bignell, M Unemo… - … journal of STD & …, 2013 - journals.sagepub.com
Gonorrhoea is a major public health concern globally. Of particularly grave concern is that
resistance to the extended-spectrum cephalosporins has emerged during the most recent …

The staying power of pharyngeal gonorrhea: implications for public health and antimicrobial resistance

PC Adamson, JD Klausner - Clinical Infectious Diseases, 2021 - academic.oup.com
Neisseria gonorrhoeae is one of the most common bacterial sexually transmitted infections
(STIs), causing approximately 87 million new infections worldwide [1]. Cases of gonorrhea …

Gentamicin Alone Is Inadequate to Eradicate Neisseria Gonorrhoeae From the Pharynx

LA Barbee, OO Soge, J Morgan, A Leclair… - Clinical infectious …, 2020 - academic.oup.com
Abstract Background Centers for Disease Control and Prevention (CDC) guidelines
recommend 240 mg gentamicin plus 2 g azithromycin for the treatment of gonorrhea in …

Is there a future for the ongoing use of azithromycin for the treatment of Neisseria gonorrhoeae?

FYS Kong, JS Hocking… - Clinical …, 2020 - clinicalmicrobiologyandinfection …
Maintaining effective treatments for Neisseria gonorrhoeae in the context of the organism's
extraordinary capacity to acquire antimicrobial resistance is challenging. Indeed, N …

Incidence and duration of incident oropharyngeal gonorrhoea and chlamydia infections among men who have sex with men: prospective cohort study

EPF Chow, LA Vodstrcil, DA Williamson… - Sexually transmitted …, 2021 - sti.bmj.com
Objectives This prospective cohort study aimed to determine the natural history and
incidence of oropharyngeal gonorrhoea and chlamydia among a cohort of men who have …